Who owns AGIOS PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AGIO from SEC Form 13F filings across 238 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 238 institutions disclosed 66.0M shares of AGIOS PHARMACEUTICALS, INC. worth $2.45B — about 111% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
238
13F holders
$2.45B
value, 2026 filers
111%
of shares outstanding (66.0M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of AGIO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.5M | $239.6M | 0.0% | 10.9% | +12.2% |
| 2 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 5.9M | $219.6M | 1.0% | 9.9% | +4.1% |
| 3 | STATE STREET CORP | 3.5M | $131.1M | 0.0% | 5.9% | +5.0% |
| 4 | Lynx1 Capital Management LP | 3.4M | $126.5M | 14.6% | 5.7% | +30.5% |
| 5 | D. E. Shaw & Co., Inc. | 3.1M | $115.3M | 0.1% | 5.2% | +15.9% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.9M | $107.6M | 0.0% | 4.9% | +11.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | $99.5M | 0.0% | 4.5% | +1.9% |
| 8 | ARMISTICE CAPITAL, LLC | 2.4M | $89.1M | 1.1% | 4% | -11.6% |
| 9 | Erste Asset Management GmbH | 2.2M | $82.0M | 0.6% | 3.6% | -20.3% |
| 10 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.1M | $78.3M | 0.1% | 3.5% | +41.2% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $58.4M | 0.0% | 2.6% | +7.2% |
| 12 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.4M | $51.0M | 0.0% | 2.3% | +2.3% |
| 13 | ADAR1 Capital Management, LLC | 1.3M | $47.8M | 2.2% | 2.2% | +815.6% |
| 14 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.3M | $47.5M | 0.0% | 2.2% | -19.0% |
| 15 | DIMENSIONAL FUND ADVISORS LP | 1.2M | $46.3M | 0.0% | 2.1% | +8.4% |
| 16 | GW&K Investment Management, LLC | 1.2M | $44.8M | 0.3% | 2% | -0.7% |
| 17 | GOLDMAN SACHS GROUP INC | 1.2M | $42.7M | 0.0% | 1.9% | +42.8% |
| 18 | UBS Group AG | 985,831 | $36.6M | 0.0% | 1.7% | +643.8% |
| 19 | MORGAN STANLEY | 963,256 | $35.7M | 0.0% | 1.6% | -0.4% |
| 20 | Nuveen, LLC | 873,560 | $32.4M | 0.0% | 1.5% | +20.9% |
| 21 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 810,530 | $30.1M | 0.0% | 1.4% | +223.6% |
| 22 | Foresite Capital Management VI LLC | 785,000 | $29.1M | 4.5% | 1.3% | +49.5% |
| 23 | CITADEL ADVISORS LLC | 732,687 | $27.2M | 0.0% | 1.2% | +18.2% |
| 24 | AQR CAPITAL MANAGEMENT LLC | 684,340 | $25.4M | 0.0% | 1.2% | +1779.5% |
| 25 | Parkman Healthcare Partners LLC | 669,046 | $24.8M | 2.5% | 1.1% | +65.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.